In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.

Autor: Denneman L; aDepartment of Paediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Centre (AMC), University of Amsterdam (UvA), Amsterdam bDepartment of Paediatrics, Amphia Hospital, Breda cDepartment of Internal Medicine dDepartment of Gynaecology and Obstetrics, AMC, UvA eHIV Monitoring Foundation fDepartment of Experimental Immunology, AMC, UvA, Amsterdam, The Netherlands. *Henriette J. Scherpbier and Madeleine J. Bunders contributed equally to the writing of this article., Cohen S, Godfried MH, van Leeuwen E, Nellen JF, Kuijpers TW, Pajkrt D, van de Plas A, Smit C, Weijsenfeld AM, Scherpbier HJ, Bunders MJ
Jazyk: angličtina
Zdroj: AIDS (London, England) [AIDS] 2016 Aug 24; Vol. 30 (13), pp. 2135-7.
DOI: 10.1097/QAD.0000000000001156
Databáze: MEDLINE